Search Results - Berrocal-Kasay, Alfredo

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus

    Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus by Zavala-Flores, Ernesto, Salcedo-Matienzo, Jannin, Quiroz-Alva, Ana, Berrocal-Kasay, Alfredo

    Published in Clinical rheumatology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2

    A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2 by Zavala-Flores, Ernesto, Salcedo-Matienzo, Jannin, Huamanchumo-Guzman, Roberto, Berrocal-Kasay, Alfredo, Alarcón, Graciela S

    Published in Lupus
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial

    Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial by Shim, Seung Cheol, Božić-Majstorović, Ljubinka, Berrocal Kasay, Alfredo, El-Khouri, Elias Chalouhi, Irazoque-Palazuelos, Fedra, Cons Molina, Francisco Fidencio, Medina-Rodriguez, Francisco G, Miranda, Pedro, Shesternya, Pavel, Chavez-Corrales, Jose, Wiland, Piotr, Jeka, Slawomir, Garmish, Olena, Hrycaj, Pawel, Fomina, Natalia, Park, Won, Suh, Chang-Hee, Lee, Sang Joon, Lee, Sung Young, Bae, Yun Ju, Yoo, Dae Hyun

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial

    Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial by Suh, Chang-Hee, Yoo, Dae Hyun, Berrocal Kasay, Alfredo, Chalouhi El-Khouri, Elia, Cons Molina, Francisco Fidenci, Shesternya, Pavel, Miranda, Pedro, Medina-Rodriguez, Francisco G., Wiland, Piotr, Jeka, Slawomir, Chavez-Corrales, Jose, Linde, Thomas, Hrycaj, Pawel, Abello-Banfi, Mauricio, Hospodarskyy, Ihor, Jaworski, Janusz, Piotrowski, Mariusz, Brzosko, Marek, Krogulec, Marek, Shevchuk, Sergii, Calvo, Armando, Andersone, Daina, Park, Won, Shim, Seung Cheol, Lee, Sang Joon, Lee, Sung Young

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

    Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial by Park, Won, Božić-Majstorović, Ljubinka, Milakovic, Dragana, Berrocal Kasay, Alfredo, El-Khouri, Elias Chalouhi, Irazoque-Palazuelos, Fedra, Molina, Francisco Fidencio Cons, Shesternya, Pavel, Miranda, Pedro, Medina-Rodriguez, Francisco G, Wiland, Piotr, Jeka, Slawomir, Chavez-Corrales, Jose, Garmish, Olena, Linde, Thomas, Rekalov, Dmytro, Hrycaj, Pawel, Krause, Andreas, Fomina, Natalia, Piura, Olena, Abello-Banfi, Mauricio, Suh, Chang-Hee, Shim, Seung Cheol, Lee, Sang Joon, Lee, Sung Young, Kim, Sung Hwan, Yoo, Dae Hyun

    Published in mAbs
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Efficacy, pharmacokinetics and safety of subcutaneous versus intravenous CT-P13 in rheumatoid arthritis: a randomized phase I/III trial

    Efficacy, pharmacokinetics and safety of subcutaneous versus intravenous CT-P13 in rheumatoid arthritis: a randomized phase I/III trial by Westhovens, Rene, Wiland, Piotr, Zawadzki, Marek, Ivanova, Delina, Kasay, Alfredo Berrocal, El-Khouri, Elias Chalouhi, Balázs, Éva, Shevchuk, Sergii, Eliseeva, Larisa, Stanislavchuk, Mykola, Yatsyshyn, Roman, Hrycaj, Paweł, Jaworski, Janusz, Zhdan, Vyacheslav, Trefler, Jakub, Shesternya, Pavel, Lee, Sang Joon, Kim, Sung Hyun, Suh, Jee Hye, Lee, Seul Gi, Han, Noo Ri, Yoo, Dae Hyun

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

    Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial by Park, Won, Božić-Majstorović, Ljubinka, Milakovic, Dragana, Berrocal Kasay, Alfredo, El-Khouri, Elias Chalouhi, Irazoque-Palazuelos, Fedra, Molina, Francisco Fidencio Cons, Shesternya, Pavel, Miranda, Pedro, Medina-Rodriguez, Francisco G., Wiland, Piotr, Jeka, Slawomir, Chavez-Corrales, Jose, Garmish, Olena, Linde, Thomas, Rekalov, Dmytro, Hrycaj, Pawel, Krause, Andreas, Fomina, Natalia, Piura, Olena, Abello-Banfi, Mauricio, Suh, Chang-Hee, Shim, Seung Cheol, Lee, Sang Joon, Lee, Sung Young, Kim, Sung Hwan, Yoo, Dae Hyun

    Published in mAbs
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: